Home

Innovative Cellular Therapeutics Holdings reported a 9.8% stake in Lyell Immunopharma LYEL · 1,900,000 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
9.8%
Last report
First report
Shares held
1,900,000 sh
Class
Common Stock, par value $0.0001
Event date
25/11/06
Filed
25/11/13

First 5%+ report · 9.8% stake

Lyell Immunopharma trades, last 26 weeks

What else happened in Lyell Immunopharma around then

Filed or reported within 30 days of the trade day · 25/10/07~25/12/06

Innovative Cellular Therapeutics Holdings's other 5% stake reports